Roche Partners With Peptide Specialist Aileron For Five Targets

A $25 million upfront commitment could blossom into a deal worth as much as $1.1 billion plus royalties.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet